Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma

Esophageal adenocarcinoma (EAC) is the fastest growing cancer in the western world and the overall 5 year survival rate of EAC is below 20%. Most patients with EAC present with locally advanced or widespread metastatic disease, where current treatment is largely ineffective. Therefore, new therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Md Sazzad, Awasthi, Niranjan, Li, Jun, Williams, Fiona, Schwarz, Margaret A., Schwarz, Roderich E., von Holzen, Urs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884213/
https://www.ncbi.nlm.nih.gov/pubmed/29475139
http://dx.doi.org/10.1016/j.tranon.2018.01.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884213/
https://www.ncbi.nlm.nih.gov/pubmed/29475139
http://dx.doi.org/10.1016/j.tranon.2018.01.022

Ejemplares similares